| Literature DB >> 31795421 |
Tahani Binaljadm1,2, Robert Moorehead1, Thafar Almela1,3, Kirsty Franklin1, Lobat Tayebi4, Keyvan Moharamzadeh1,4.
Abstract
Restoring subgingival class-V cavities successfully, demand special biological properties from a restorative material. This study aimed to assess the effects of incorporating bioactive materials to glass ionomer cement (GIC) on its mechanical and biological properties. Hydroxyapatite, chitosan, chondroitin sulphate, bioglass, gelatine and processed bovine dentin were incorporated into a GIC restorative material. Compressive strength, biaxial flexural strength (BFS), hardness, setting and working time measurements were investigated. Biocompatibility of the new materials was assessed using both monolayer cell cultures of normal oral fibroblasts (NOF) and TR146 keratinocytes, and a 3D-tissue engineered human oral mucosa model (3D-OMM) using presto-blue tissue viability assay and histological examination. Significant reduction in the compressive strength and BFS of gelatine-modified discs was observed, while chondroitin sulphate-modified discs had reduced BFS only (p value > 0.05). For hardness, working and setting times, only bioglass caused significant increase in the working time. NOF viability was significantly increased when exposed to GIC-modified with bovine dentine, bioglass and chitosan. Histological examination showed curling and growth of the epithelial layer toward the disc space, except for the GIC modified with gelatine. This study has highlighted the potential for clinical application of the modified GICs with hydroxyapatite, chitosan, bioglass and bovine dentine in subgingival class-V restorations.Entities:
Keywords: biocompatibility; biomodification; dental materials; glass ionomer cement; oral mucosa
Year: 2019 PMID: 31795421 PMCID: PMC6960733 DOI: 10.3390/dj7040110
Source DB: PubMed Journal: Dent J (Basel) ISSN: 2304-6767
Mean values and standard deviations of the results of the mechanical tests for different test groups. * Represents statistically significant difference from the control group (p < 0.05).
| Working Time (Minutes) | Setting Time (Minutes) | BFS (MPa) | Hardness (MPa) | Compressive Strength (MPa) | |
|---|---|---|---|---|---|
|
| 5.1 (0.5) | 1.6 (0.5) | 33.1 (6.8) | 49.5 (6.8) | 112.3 (17.1) |
|
| 6.6 (0.5) | 1.6 (0.4) | 31.4 (5.1) | 52.6 (13.1) | 129.5 (26.5) |
|
| 5.9 (0.5) | 1.7 (0.3) | 31.0 (4.0) | 47.9 (13.9) | 111.3 (25.9) |
|
| 6.7 * (1.2) | 2.0 (0.3) | 32.0 (2.1) | 46.3 (15.6) | 91.0 (14.9) |
|
| 6.0 (0.3) | 2.4 (0.5) | 21.8 (6.3) | 41.4 (18.7) | 44.2 * (16.6) |
|
| 6.2 (0.7) | 2.2 (0.8) | 35.0 (4.4) | 37.5 (11.8) | 50.5 * (10.8) |
|
| 4.9 (0.3) | 1.2 (0.3) | 35.0 (4.4) | 49.1 (23.3) | 97.1 (14.7) |
Figure 1Cell viability of normal oral fibroblasts (NOFs) and TR146 exposed to test materials (10% by weight bioactive material and 90% glass ionomer cement (GIC)) and GIC discs used as a control.
Figure 2Tissue viability of 3D human oral mucosa model (3D-OMM) exposed to test materials (10% by weight bioactive material and 90% GIC) and GIC discs used as a control.
Figure 3Histological sections (H&E staining) of OMM showing (A) the epithelial and connective tissue layers and (B) curling of the epithelial layer towards the GIC disc space and forming junctional epithelium.
Figure 4Test samples within 3D oral mucosal model. The upper panel shows the dissolution of discs fabricated from GIC modified with gelatine after 24 h. The lower panel shows stable GIC discs within 3D oral mucosal models.